Anatara Lifesciences Share Price and Company Fundamentals
Last traded: Today at 4:41 AM
Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company's products include Gastrointestinal ReProgramming, a multi-component, multi-coated medicine designed to address underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and Detach for the treatment of diarrhea in piglets. It also develops anti-obesity project, an oral medication to assist weight reduction and control. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.
Key Metrics
PE ratio
-
PB ratio
3.67
Dividend yield
-
Beta
0.65
Market cap
$3.45M
Enterprise value
$2.65M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://anataralifesciences.com |
| Mailing address | 81 Flinders Street Level 8 Adelaide SA 5000 Australia |
| Phone / Fax | 61 4 3802 7172 / 61 4 3802 7172 |
Dividends
More: Anatara Lifesciences Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Anatara Lifesciences paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ANR dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Anatara Lifesciences.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS | Executive Chairman & MD | 65 | |
| Mr. Simon Erskine | Chief Development Officer | ||
| Mr. Jonathan Lindh | Company Secretary | ||
| Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management | Commercial Manager |
Profitability and management effectiveness
Profit margin
-201.63%
Operating margin
-177.30%
Return on assets
-86.74%
Return on equity
-205.70%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Anatara Lifesciences is 3.45M and its enterprise value is 2.65M. The enterprise value to revenue ratio of ANR is 2.74. The enterprise value to EBITDA ratio of ANR is -1.36.
The ANR's stocks Beta value is 0.65 making it 35% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Anatara Lifesciences (ANR)
Anatara Lifesciences (ASX:ANR) Frequently Asked Questions
1. What is Anatara Lifesciences's Stock Symbol?
Anatara Lifesciences trades on ASX under the ticker symbol "ANR".
2. What is Anatara Lifesciences's stock price today?
One share of ANR stock can currently be purchased for approximately $0.011.
3. How can I contact Anatara Lifesciences?
Anatara Lifesciences's mailing address is 81 Flinders Street Level 8 Adelaide SA 5000 Australia. The company can be reached via phone at 61 4 3802 7172.
4. What is Anatara Lifesciences's official website?
The official website of Anatara Lifesciences is https://anataralifesciences.com.